We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
-3.68%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$44.3B
AUM Growth
-$9.51B
Cap. Flow
-$5.48B
Cap. Flow %
-12.38%
Top 10 Hldgs %
12.78%
Holding
2,408
New
212
Increased
800
Reduced
967
Closed
238

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$1.01B
2
NBIS
Nebius Group N.V.
NBIS
+$257M
3
CVX icon
Chevron
CVX
+$236M
4
XOM icon
ExxonMobil
XOM
+$224M
5
ABBV icon
AbbVie
ABBV
+$184M

Sector Composition

Rank Sector Weight
1 Healthcare 22.65%
2 Technology 17.13%
3 Financials 12.56%
4 Consumer Discretionary 8.83%
5 Industrials 7.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZVO
2051
DELISTED
Zovio Inc. Common Stock
ZVO
$2K ﹤0.01%
+2,199
New +$2.48K
MSP
2052
DELISTED
Datto Holding Corp.
MSP
$2K ﹤0.01%
+58
New +$1.44K
ACEL icon
2053
Accel Entertainment
ACEL
$943M
$1K ﹤0.01%
+34
New +$439
AIV
2054
Aimco
AIV
$333M
$1K ﹤0.01%
2
-16,043
-100% -$114K
AKRO
2055
DELISTED
Akero Therapeutics
AKRO
$1K ﹤0.01%
+14
New +$245
ALHC icon
2056
Alignment Healthcare
ALHC
$2.11B
$1K ﹤0.01%
+2
New +$18
AMS icon
2057
American Shared Hospital Services
AMS
$9.64M
$1K ﹤0.01%
216
-284
-57% -$657
APLT
2058
DELISTED
Applied Therapeutics
APLT
$1K ﹤0.01%
+519
New +$1.39K
AQB icon
2059
AquaBounty Technologies
AQB
$5.76M
$1K ﹤0.01%
22
+10
+83% +$348
AROC icon
2060
Archrock
AROC
$5.3B
$1K ﹤0.01%
+2
New +$17
ARVN icon
2061
Arvinas
ARVN
$545M
$1K ﹤0.01%
2
-12
-86% -$818
ATEN icon
2062
A10 Networks
ATEN
$1.93B
$1K ﹤0.01%
39
-338
-90% -$4.75K
AVAH icon
2063
Aveanna Healthcare
AVAH
$3.07B
$1K ﹤0.01%
4
+3
+300% +$16
BATL icon
2064
Battalion Oil
BATL
$75M
$1K ﹤0.01%
+53
New +$847
BDSX icon
2065
Biodesix
BDSX
$286M
$1K ﹤0.01%
+8
New +$523
BRY
2066
DELISTED
Berry Corp
BRY
$1K ﹤0.01%
2
-141
-99% -$1.34K
BWEN icon
2067
Broadwind
BWEN
$92.3M
$1K ﹤0.01%
414
+211
+104% +$411
CABA icon
2068
Cabaletta Bio
CABA
$444M
$1K ﹤0.01%
+149
New +$390
CBUS icon
2069
Cibus
CBUS
$113M
$1K ﹤0.01%
+11
New +$822
CIVB icon
2070
Civista Bancshares
CIVB
$572M
$1K ﹤0.01%
+52
New +$1.26K
CRBP icon
2071
Corbus Pharmaceuticals
CRBP
$132M
$1K ﹤0.01%
52
-7
-12% -$93
CRD.B icon
2072
Crawford & Co Class B
CRD.B
$554M
$1K ﹤0.01%
144
CRDF icon
2073
Cardiff Oncology
CRDF
$105M
$1K ﹤0.01%
+152
New +$538
CTBI icon
2074
Community Trust Bancorp
CTBI
$1.4B
$1K ﹤0.01%
32
-3
-9% -$130
CTMX icon
2075
CytomX Therapeutics
CTMX
$604M
$1K ﹤0.01%
81
-961,393
-100% -$3.69M

Similar funds

Federated Hermes's Q1 2022 Portfolio in Review

As of Q1 2022, Federated Hermes held 2,408 positions worth $44.3B, down 18% from $53.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Federated Hermes withdrew a net $5.48B in Q1 2022, closing 238 positions and reducing 967 holdings. Its most notable exit was Nebius Group N.V., an estimated $257M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Financials.

Against the trend, Federated Hermes opened a new position in Apollo Global Management worth $44.5M.

  • Federated Hermes's largest Q1 2022 buy was Apollo Global Management: 718,400 shares worth $44.5M.
  • Federated Hermes added most to Clorox in Q1 2022, an estimated $160M increase.
  • Federated Hermes's biggest Q1 2022 reduction was TSMC, cutting an estimated $1.01B.
  • Federated Hermes fully exited Nebius Group N.V. in Q1 2022, selling an estimated $257M.
  • Federated Hermes's ten largest holdings make up 13% of its $44.3B portfolio in Q1 2022.
  • Federated Hermes opened 212 new positions and closed 238 in Q1 2022.
  • Federated Hermes's portfolio value fell 18% quarter-over-quarter to $44.3B.

Based on Federated Hermes's 13F filing for Q1 2022, filed 13 May 2022.